KR100203959B1 - 사람 망막아세포종양 유전자 생성물의 인산화의 세포-주기-의존적 조절방법 - Google Patents

사람 망막아세포종양 유전자 생성물의 인산화의 세포-주기-의존적 조절방법 Download PDF

Info

Publication number
KR100203959B1
KR100203959B1 KR1019920701332A KR920701332A KR100203959B1 KR 100203959 B1 KR100203959 B1 KR 100203959B1 KR 1019920701332 A KR1019920701332 A KR 1019920701332A KR 920701332 A KR920701332 A KR 920701332A KR 100203959 B1 KR100203959 B1 KR 100203959B1
Authority
KR
South Korea
Prior art keywords
protein
phosphorylation
cell
cells
drug
Prior art date
Application number
KR1019920701332A
Other languages
English (en)
Korean (ko)
Inventor
카이 펑 옌
Original Assignee
이. 엘. 나가부샨
캔지, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이. 엘. 나가부샨, 캔지, 인크. filed Critical 이. 엘. 나가부샨
Application granted granted Critical
Publication of KR100203959B1 publication Critical patent/KR100203959B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/22—Testing for sterility conditions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4736—Retinoblastoma protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Thermal Transfer Or Thermal Recording In General (AREA)
  • Luminescent Compositions (AREA)
KR1019920701332A 1989-12-07 1990-12-07 사람 망막아세포종양 유전자 생성물의 인산화의 세포-주기-의존적 조절방법 KR100203959B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44728289A 1989-12-07 1989-12-07
US7/447,282 1989-12-07
PCT/US1990/007216 WO1991009114A1 (en) 1989-12-07 1990-12-07 Cell-cycle-dependent regulation of phosphorylation of human retinoblastoma gene product

Publications (1)

Publication Number Publication Date
KR100203959B1 true KR100203959B1 (ko) 1999-06-15

Family

ID=23775728

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920701332A KR100203959B1 (ko) 1989-12-07 1990-12-07 사람 망막아세포종양 유전자 생성물의 인산화의 세포-주기-의존적 조절방법

Country Status (17)

Country Link
EP (1) EP0504289B1 (pt)
JP (1) JP3080402B2 (pt)
KR (1) KR100203959B1 (pt)
CN (1) CN1052607A (pt)
AT (1) ATE184653T1 (pt)
AU (1) AU653142B2 (pt)
CA (1) CA2070660A1 (pt)
DE (1) DE69033289T2 (pt)
ES (1) ES2135390T3 (pt)
FI (1) FI922615A (pt)
IE (1) IE904400A1 (pt)
IL (1) IL96575A (pt)
NO (1) NO922168L (pt)
NZ (1) NZ236391A (pt)
PT (1) PT96110A (pt)
WO (1) WO1991009114A1 (pt)
ZA (1) ZA909755B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223842B1 (en) 1986-08-11 2007-05-29 Massachusetts Eye And Ear Infirmary Detection of proteins whose absence is associated with a neoplasm
US7384735B1 (en) 1986-08-11 2008-06-10 Massachusetts Eye And Ear Infirmary Retinoblastoma nucleic acids
US5851991A (en) * 1987-08-31 1998-12-22 The Regents Of The University Of California Therapeutic use of the retinoblastoma susceptibility gene product
US7105156B1 (en) 1987-09-17 2006-09-12 The Regents Of The University Of California Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells
TW346397B (en) * 1991-10-17 1998-12-01 Univ California Cell cycle controlling compositions and methods of using same
ZA946595B (en) * 1993-09-03 1996-02-28 Res Dev Foundation Mutants of the retinoblastoma and P53 genes and uses thereof
US5969120A (en) * 1993-09-03 1999-10-19 Research Development Foundation Mutants of the RB and P53 genes
GB9506050D0 (en) 1995-03-24 1995-05-10 Osteometer A S Assaying collagen fragments in body fluids
DE69520111T2 (de) 1994-10-17 2001-09-06 Osteometer Biotech As Herlev Schätzung des Fragmentierungsmusters von Kollagen in Körperflüssigkeiten und Diagnose von mit dem Kollagenmetabolismus zusammenhängenden Störungen
AU4502096A (en) * 1994-11-11 1996-06-06 Arch Development Corporation A process of inhibiting non-neoplastic pathological cell proliferation
US6107047A (en) * 1996-03-21 2000-08-22 Osteometer Biotech A/S Assaying protein fragments in body fluids
GB9617616D0 (en) 1996-08-22 1996-10-02 Osteometer Biotech As Assaying protein fragments in body fluids
WO1998026286A2 (en) 1996-12-09 1998-06-18 Osteometer Biotech A/S Sandwich assays for collagen type i fragments
US6117646A (en) * 1997-09-22 2000-09-12 Osteometer Biotech A/S Assaying protein fragments in body fluids
JP6142068B1 (ja) * 2016-12-13 2017-06-07 株式会社マスダック サンドウィッチパンケーキ製造装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5888801A (ja) * 1981-11-20 1983-05-27 Hitachi Ltd 磁気デイスク記憶装置
US4694023A (en) * 1982-06-28 1987-09-15 Usv Pharmaceutical Corporation Alpha-alkyl polyolefinic carboxylic acids and derivatives thereof useful in the treatment of psoriasis and allergic responses
US4797762A (en) * 1987-09-22 1989-01-10 Micropolis Corporation Stress free winchester drive shaft mounting

Also Published As

Publication number Publication date
JP3080402B2 (ja) 2000-08-28
DE69033289T2 (de) 2000-01-05
NO922168D0 (no) 1992-06-01
NO922168L (no) 1992-07-15
EP0504289B1 (en) 1999-09-15
JPH05503421A (ja) 1993-06-10
ATE184653T1 (de) 1999-10-15
CN1052607A (zh) 1991-07-03
PT96110A (pt) 1991-09-30
IL96575A (en) 1995-05-26
FI922615A0 (fi) 1992-06-05
WO1991009114A1 (en) 1991-06-27
ZA909755B (en) 1991-09-25
ES2135390T3 (es) 1999-11-01
NZ236391A (en) 2001-07-27
IL96575A0 (en) 1991-09-16
EP0504289A4 (en) 1993-03-31
EP0504289A1 (en) 1992-09-23
AU653142B2 (en) 1994-09-22
AU7038991A (en) 1991-07-18
DE69033289D1 (de) 1999-10-21
FI922615A (fi) 1992-06-05
IE904400A1 (en) 1991-06-19
CA2070660A1 (en) 1991-06-08

Similar Documents

Publication Publication Date Title
Mihara et al. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product
KR100203959B1 (ko) 사람 망막아세포종양 유전자 생성물의 인산화의 세포-주기-의존적 조절방법
JP3745558B2 (ja) 腫瘍タンパク質のプロテインキナーゼ
Hanada et al. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells
Poluha et al. The cyclin-dependent kinase inhibitor p21WAF1 is required for survival of differentiating neuroblastoma cells
AU700350B2 (en) Novel mammalian cell cycle protein
Wang et al. Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153)
Sheard et al. Up‐regulation of Fas (CD95) in human p53wild‐type cancer cells treated with ionizing radiation
Wadhwa et al. Expression of the neurotrophin receptors Trk A and Trk B in adult human astrocytoma and glioblastoma
Livneh et al. Linking protein kinase C to the cell cyele: ectopic expression of PKCll NIH3T3 cells alters the expression of cyelins and Cdk inhibitors and induces adipogenesis
US20060121527A1 (en) Oncoprotein protein kinase
Ling et al. Radiation-induced apoptosis: effects of cell age and dose fractionation
WO1993018147A1 (en) Protein compound capable of inhibiting tumoral growth
RU2192431C2 (ru) Синтетический мутантный ген rb (варианты), синтетический мутантный ген p53, плазмида (варианты), мутантный белок (варианты), способ ингибирования клеточной пролиферации (варианты), способ индуцирования апоптоза
US6641995B2 (en) Methods for identifying cell cycle regulators
Nadal Synchronization of baby rat hepatocytes: a new test for the detection of factors controlling DNA synthesis in rat hepatic cells
Tsuda et al. Increased solubility of high‐molecular‐mass neurofilament subunit by suppression of dephosphorylation: its relation to axonal transport
TABUCHI et al. Demonstration of proliferating cell nuclear antigen (PCNA/cyclin) in glioma cells
Lee et al. Translocation of nuclear factor-κB on corneal epithelial cells induced by ultraviolet B irradiation
Raptis et al. Protein kinase C promotes the phosphorylation of immunoprecipitated middle T antigen from polyoma-transformed cells
KR100386899B1 (ko) Rb및p53유전자의돌연변이체및이의용도
US7056908B2 (en) Pharmaceutical compositions and methods for preventing skin tumor formation and causing regression of existing tumors
de la Monte et al. Modulation of p36 gene expression in human neuronal cells
US6200810B1 (en) Mutants of the Rb and p53 genes and uses thereof
Vincent et al. Differential expression between PAX-6 and EN proteins in medulloblastoma

Legal Events

Date Code Title Description
N231 Notification of change of applicant
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20060327

Year of fee payment: 8

LAPS Lapse due to unpaid annual fee